| Literature DB >> 25336551 |
Umberto Volpe1, Annarita Vignapiano1, Olimpia Gallo1, Michele Fabrazzo1.
Abstract
Anecdotal evidence tends to favour olanzapine in the treatment of hallucinations in patients with schizophrenia spectrum disorders; however, no conclusive evidence is available on this topic. We report here a clinical case in which a 46-year-old man, suffering from a schizoaffective disorder (depressed type), underwent olanzapine treatment (20 mg/day). After inducing an initial amelioration, the patient had a re-exacerbation of auditory hallucinations and a clinical and psychosocial worsening, which subsided after olanzapine discontinuation. Olanzapine may induce a worsening of hallucinations in a psychotic disorder with substantial affective component and therefore its use should be carefully evaluated in such cases. 2014 BMJ Publishing Group Ltd.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25336551 PMCID: PMC4208114 DOI: 10.1136/bcr-2014-205805
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X